HJ
Therapeutic Areas
Sorrento Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Abivertinib | Non-Small Cell Lung Cancer (NSCLC) | Phase 3 |
| Resiniferatoxin (RTX) | Severe knee osteoarthritis pain | Phase 3 |
| Oregovomab | Advanced ovarian cancer | Phase 3 |
| MSC-1 (anti-LIF mAb) | Metastatic solid tumors | Phase 1 |
| Seprehvec | Refractory solid tumors | Phase 1 |
| COVID-19 STI-2020 (mAb) | COVID-19 | Phase 2 |